Phase II study of capecitabine (Xeloda®) and concomitant boost radiotherapy in patients with locally advanced rectal cancer
Sunil Krishnan, Nora A. Janjan, John M. Skibber, Miguel A. Rodriguez-Bigas, Robert A. Wolff, Prajnan Das, Marc E. Delclos, George J. Chang, Paulo M. Hoff, Cathy Eng, Thomas D. Brown, Christopher H. CrVolume:
66
Year:
2006
Language:
english
Pages:
10
DOI:
10.1016/j.ijrobp.2006.05.063
File:
PDF, 231 KB
english, 2006